Alternatives to C4 Therapeutics

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Engineering scalable gene therapies for broader patient populations.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

A global oncology company developing and commercializing innovative cancer treatments.

Developing engineered biologics to harness the immune system for disease treatment.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Biotechnology company developing novel immunotherapies for cancer.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.

Develops novel therapeutic antibodies for oncology and autoimmune diseases.

Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Leveraging the adaptive immune system to diagnose and treat disease.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotech company developing novel therapeutics for regenerative medicine and oncology.

AI-powered platform for personalized cell therapy development and manufacturing.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Biotech company developing next-generation gene writing tools for advanced therapies.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

Gene therapy company developing treatments for rare inherited diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Pillar Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel cancer therapies.

Developing novel therapeutics for cancer by targeting the tumor microenvironment.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Biopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.

Developing novel therapeutics for challenging diseases using advanced biological insights.

Biotech company focused on developing therapies to extend human healthspan and lifespan.

Develops and manufactures biologics for therapeutic applications.

Metly empowers pharma companies to accelerate product launches through intelligent opportunity detection and partner matching.

Global marketplace connecting researchers with human biospecimens for life science research.

Developing advanced cell culture media and bioprocessing solutions for cell and gene therapy.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

VISEN Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies for inflammatory and fibrotic diseases.

AI-powered spatial biology platform for precision medicine and drug development.